PharmStars

JOGO Health is a virtual care company that specializes in digital therapeutics aimed at treating pain, neuromuscular conditions, and pelvic floor disorders. Utilizing clinically proven digital interventions, the company develops an AI-driven mobile app paired with wearable sensors that deliver tailored treatment protocols. These offerings include games and exercises designed for muscle relaxation, movement coordination, and neuromuscular reeducation, all leveraging the brain's neuroplasticity. By enhancing patient adherence to rehabilitation programs, JOGO Health enables healthcare providers to achieve improved health outcomes for conditions such as chronic pain, stroke recovery, and pelvic health issues.

Lumia Health is a digital health company enhancing quality of life for individuals with cardiovascular and neurological conditions, initially focusing on orthostatic syndromes. It achieves this through its in-ear wearable device and targeted software programs built upon continuous cardiac data.

Innsightful develops wearable devices that monitor and detect anxiety and stress symptoms using AI and machine learning. Their solution integrates biometrics for early detection and provides access to therapists for personalized recommendations, empowering users to understand and manage their mental health.

My Moves Matter offers a patient-centric digital platform designed to empower individuals living with Parkinson's disease. The platform provides tools for proactive self-management, including symptom tracking via a mobile app and personalized nutrition guidance tailored to Parkinson's care.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2014, Health Care Originals develops innovative solutions for managing chronic respiratory diseases. The company's flagship product is ADAMM, a three-part system consisting of a wearable device, smartphone application, and web portal. ADAMM monitors precursor symptoms of asthma attacks by tracking physiological characteristics such as cough counting, respiration, wheeze, and heart rate.

Founded in 2020, GPx is a Boston-based biotech company specializing in remote chronic disease management. It offers bloodless blood tests to transform the standard of care for cardiorenal diseases, empowering patients with better understanding of their condition.

Biostrap develops a wearable device for continuous biometric tracking, offering clinical-grade sensors that measure heart rate variability, respiratory rate, blood oxygen saturation, sleep metrics, and more. Its advanced analytics and remote monitoring capabilities enable healthcare providers and research institutions to deliver personalized health insights and improve patient outcomes.

Orbit Health specializes in developing artificial intelligence solutions for personalized treatment of Parkinson's disease.

HealthQb is a health technology company that enables remote monitoring and management of biopsychosocial health. Its platform provides clinicians and other health providers with objective patient data gathered through wearables and a patient application, supporting triage and care decisions that help individuals reach their health goals. The system tracks biopsychosocial metrics via wearable devices and a healthcare portal to support remote monitoring and behavior change guidance, targeting patients with chronic illnesses. By identifying root causes of health behaviors and offering ongoing coaching and feedback, HealthQb aims to sustain healthy behaviors and improve long-term outcomes across care settings such as rehabilitation, physiotherapy, and primary care.

The Clinician Ltd is a health IT company based in Auckland, New Zealand, with an additional office in Singapore. Established in 2015, it specializes in enhancing patient engagement and care outcomes through its flagship product, ZeDoc, a cloud-based platform designed for patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs). The platform facilitates the distribution, collection, and analysis of PROMs data throughout the patient care continuum, integrating seamlessly into existing clinical workflows. Utilizing artificial intelligence-driven chatbots and data science techniques, ZeDoc minimizes the burden of patient questionnaires and enables real-time monitoring of patient feedback. This innovative approach allows healthcare providers to assess patient cohorts, identify at-risk cases, and implement necessary interventions, ultimately supporting a patient-centric value-based care model. The Clinician is recognized as a first mover in the Asia Pacific region, with a management team possessing extensive experience across medicine, engineering, research, and business intelligence.

nQ Medical Inc., founded in 2016 and based in Cambridge, Massachusetts, is a digital therapeutics company focused on transforming the management of neurocognitive and neuromotor disorders. The company has developed an artificial intelligence tool called neuroQWERTY that facilitates early detection and remote monitoring of diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. By passively collecting data from users' interactions with everyday electronic devices, nQ Medical captures subtle changes in motor function and cognitive abilities that may indicate disease progression. This innovative approach allows for continuous, non-invasive monitoring without requiring specific tasks from users, making it a cost-effective alternative to traditional diagnostic methods. The platform not only diagnoses conditions but also tracks therapeutic effectiveness, enabling better communication between clinicians and patients. By focusing on early detection and reliable disease progression markers, nQ Medical aims to enhance the management of neurological disorders and prepare for the future introduction of disease-modifying therapies.